Infrared Lymphangiography as a Method of Sentinel Node Identification

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

February 29, 2016

Conditions
MelanomaSentinel Node
Interventions
DRUG

Indocyanine green

Subjects receive 0.9ml of ICG subcutaneously about the primary melanoma. The ICG has an infrared signal that is detected with the SPY Elite system (Lifecell). The ICG travels through the lymphatics to the sentinel node.

DRUG

Technetium99

Technetium99 is a standard, widely used radiopharmaceutical that is injected subcutaneoulsy about the primary melanoma site. Lymphoscintigraphy is performed to identify the draining nodal basin, and a gamma probe is used in the operating room to track the radioactive signal and find the sentinel node.

DRUG

Methylene blue

Subjects receive 0.5-2ml of methylene blue subcutaneously about the primary melanoma at the time of surgery. The sentinel node should turn blue, which is visible with the naked eye.

Trial Locations (1)

17033

Penn State Milton S. Hershey Medical Center, Hershey

All Listed Sponsors
lead

Milton S. Hershey Medical Center

OTHER

NCT02057393 - Infrared Lymphangiography as a Method of Sentinel Node Identification | Biotech Hunter | Biotech Hunter